choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Novimmune IPO

Novimmune IPO Newsletter
  • Tiziana Life IPO: Phase 2 Of Development, But Expensive Shares 23 Oct 2018 15:22 GMT

    … 2a Clinical Trials Conducted by Novimmune The most promising interesting results … use the proceeds from the IPO to finance the Phase … $13.83 million after the IPO. Additionally, the company expects to … of shares outstanding after the IPO will equal 126.927 …

  • Tiziana Life Sciences Plans To Raise $16 Million In U.S. IPO 27 Sep 2018 17:58 GMT

    … IP for the product from Novimmune, which had studied it in … for the IPO, which is typical for current life science IPOs in … negative signal for IPO investors. Assuming a successful IPO at the … Commentary Opinion on the IPO Members of IPO Edge get the latest …

  • Tiziana Life Sciences Files For Small IPO 31 Jul 2018 19:27 GMT

    … opinion when we learn more IPO details from management. Company … IP for the product from Novimmune, which had studied it in … & Company [UK]. Expected IPO Pricing Date: Not on calendar … Commentary Opinion on the IPO Members of IPO Edge get the latest …

  • Forty Seven IPO: Google Has A Stake, But Other Competitors Trade At Lower Valuations 06 Jul 2018 20:28 GMT

    … the financial situation before the IPO may not appreciate that … were converted right before the IPO goes live. Only traders … 035 million shares in the IPO, the number of shares … ), Surface Oncology (NASDAQ:SURF), Novimmune SA, OSE Immunotherapeutics SA (OTC …

  • Forty Seven Readies $100 Million U.S. IPO 21 Jun 2018 17:43 GMT

    … ARTH) Surface Oncology (SURF) Novimmune OSE Immunotherapeutics (0RAD.L) Aurigene … a successful IPO, the company’s post-IPO market capitalization … Alpha Marketplace research service IPO Edge includes: - Valuation … Opinion on the IPO Members of IPO Edge get the …

  • Surface Oncology Proposes IPO Terms 09 Apr 2018 17:17 GMT

    … Celgene (CELG) Forty Seven Novimmune OSE Immunotherapeutics (OSE) Sorrento … biopharma firms that successfully IPO. Additionally, Novartis has … a successful IPO, the company’s post-IPO market capitalization … .S. IPOs and members learn the latest IPO research, …

  • Surface Oncology Files For $75 Million IPO 05 Apr 2018 12:43 GMT

    … learn more details about the IPO. Company Cambridge, MA- … Celgene (CELG) Forty Seven Novimmune OSE Immunotherapeutics (OSE) Sorrento … million in total liabilities. IPO Details Surface Oncology intends … U.S. IPOs and members learn the latest IPO research, news …

  • Change of Leadership at Novimmune S.A. 21 Dec 2015 14:34 GMT

    … well as scientific validation, of Novimmune's lead compound … possible trade sale or an IPO of parts or all … shareholders' meeting. About Novimmune Novimmune SA is a Swiss biopharmaceutical … the company website at www.novimmune.com. Eduard Holdener +41 …

  • Autolus Announces Appointment of Andrew J. Oakley as Senior Vice President and Chief Financial Officer 08 Jun 2018 11:39 GMT

    … the closing of Autolus’ planned initial public offering. Dr. Christian Itin, Autolus’ Chairman … , as chief financial officer of NovImmune SA from March 2014 to …

  • CD47 Targeting Therapeutics Market Industry Trends and Global Forecasts, 2021-2035 - ResearchAndMarkets.com 13 Dec 2021 14:13 GMT

    … /awards, capital raised from IPOs and subsequent offerings that were … Morphiex Biotherapeutics Mountain Pacific Venture Novimmune Novo Nordisk Ono Pharmaceutical Oriella …

Satisfied with the content?

Continue to create your account.